Pakistan Oxygen（PAKOXY）株式概要パキスタン・オキシジェン・リミテッドは、パキスタンで工業用・医療用ガス、医療エンジニアリング、パイプライン設計サービス、医療機器、溶接製品、関連ソリューションを製造・販売しています。 詳細PAKOXY ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績5/6財務の健全性6/6配当金0/6報酬当社が推定した公正価値より46.9%で取引されている 過去1年間で収益は112.8%増加しました リスク分析意味のある時価総額がありません ( PKR25B )すべてのリスクチェックを見るPAKOXY Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValuePK₨Current PricePK₨281.4442.0% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture029b2016201920222025202620282031Revenue PK₨29.5bEarnings PK₨4.2bAdvancedSet Fair ValueView all narrativesPakistan Oxygen Limited 競合他社Ghani Global HoldingsSymbol: KASE:GGLMarket cap: PK₨8.0bAgritechSymbol: KASE:AGLMarket cap: PK₨34.9bNimir Industrial ChemicalsSymbol: KASE:NICLMarket cap: PK₨25.3bSitara Chemical IndustriesSymbol: KASE:SITCMarket cap: PK₨18.7b価格と性能株価の高値、安値、推移の概要Pakistan Oxygen過去の株価現在の株価PK₨281.4452週高値PK₨356.6852週安値PK₨144.00ベータ0.351ヶ月の変化4.65%3ヶ月変化12.95%1年変化87.81%3年間の変化206.01%5年間の変化183.71%IPOからの変化336.94%最新ニュースお知らせ • Jun 16Pakistan Oxygen Limited Announces Resignation of Mazhar Iqbal as Company Secretary, Effective June 14, 2026Pakistan Oxygen Limited informed that Mr. Mazhar Iqbal has resigned from the position of Company Secretary of Pakistan Oxygen Limited, with effect from June 14, 2026.お知らせ • Apr 14Pakistan Oxygen Limited to Report Q1, 2026 Results on Apr 27, 2026Pakistan Oxygen Limited announced that they will report Q1, 2026 results on Apr 27, 2026Reported Earnings • Apr 12Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024)Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 04Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024)Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 03Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026. Location: west wharf, dockyard road, karachi Pakistanお知らせ • Feb 14Pakistan Oxygen Limited to Report Fiscal Year 2025 Results on Feb 27, 2026Pakistan Oxygen Limited announced that they will report fiscal year 2025 results on Feb 27, 2026最新情報をもっと見るRecent updatesお知らせ • Jun 16Pakistan Oxygen Limited Announces Resignation of Mazhar Iqbal as Company Secretary, Effective June 14, 2026Pakistan Oxygen Limited informed that Mr. Mazhar Iqbal has resigned from the position of Company Secretary of Pakistan Oxygen Limited, with effect from June 14, 2026.お知らせ • Apr 14Pakistan Oxygen Limited to Report Q1, 2026 Results on Apr 27, 2026Pakistan Oxygen Limited announced that they will report Q1, 2026 results on Apr 27, 2026Reported Earnings • Apr 12Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024)Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 04Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024)Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 03Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026. Location: west wharf, dockyard road, karachi Pakistanお知らせ • Feb 14Pakistan Oxygen Limited to Report Fiscal Year 2025 Results on Feb 27, 2026Pakistan Oxygen Limited announced that they will report fiscal year 2025 results on Feb 27, 2026お知らせ • Jan 30Pakistan Oxygen Limited Announces Directorate Changes, Effective January 30, 2026Pakistan Oxygen Limited elected directors at the extra ordinary genera meeting for a term of 3 years commencing from Janaury 30, 2026. Mr. Muhammad Ashraf Bawany, Mr. Arshad Mohsin Tayebaly Ms. Sadia Khan, Mrs. Saadia Naveed, Mr. Sohail Razi Khan.Valuation Update With 7 Day Price Move • Nov 13Investor sentiment improves as stock rises 16%After last week's 16% share price gain to PK₨333, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 226% over the past three years.Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to PK₨279, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 179% over the past three years.お知らせ • Oct 15Pakistan Oxygen Limited to Report Q3, 2025 Results on Oct 24, 2025Pakistan Oxygen Limited announced that they will report Q3, 2025 results on Oct 24, 2025Reported Earnings • Aug 29Second quarter 2025 earnings released: EPS: PK₨5.85 (vs PK₨1.52 in 2Q 2024)Second quarter 2025 results: EPS: PK₨5.85 (up from PK₨1.52 in 2Q 2024). Revenue: PK₨3.12b (up 13% from 2Q 2024). Net income: PK₨510.1m (up 285% from 2Q 2024). Profit margin: 16% (up from 4.8% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 37% per year whereas the company’s share price has increased by 34% per year.New Risk • Aug 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.6x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (PK₨21.1b market cap, or US$74.6m).Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improves as stock rises 22%After last week's 22% share price gain to PK₨183, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 95% over the past three years.Reported Earnings • Apr 28First quarter 2025 earnings released: EPS: PK₨4.49 (vs PK₨2.05 in 1Q 2024)First quarter 2025 results: EPS: PK₨4.49 (up from PK₨2.05 in 1Q 2024). Revenue: PK₨2.95b (up 8.1% from 1Q 2024). Net income: PK₨391.5m (up 119% from 1Q 2024). Profit margin: 13% (up from 6.5% in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year.Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 19%After last week's 19% share price gain to PK₨161, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 9x in the Chemicals industry in Pakistan. Total returns to shareholders of 50% over the past three years.お知らせ • Mar 03Pakistan Oxygen Limited, Annual General Meeting, Apr 24, 2025Pakistan Oxygen Limited, Annual General Meeting, Apr 24, 2025. Location: at the company`s registered office, west wharf, dockyard road, karachi Pakistanお知らせ • Mar 01Pakistan Oxygen Limited Appoints Asad Said Jafar as Independent DirectorPakistan Oxygen Limited has announced the appointment of Mr. Asad Said Jafar as an Independent Director, succeeding Mr. Atif Aslam Bajwa. The decision was made during the company's Board of Directors meeting held on February 27, 2025. The appointment is effective immediately, from February 27, 2025. The Board of Directors has made this strategic appointment to ensure continued governance and oversight within the company. The company has not disclosed further details regarding the future direction or priorities under the new directorship, and it remains to be seen how Mr. Jafar's leadership will influence the company's trajectory.Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: PK₨1.68 (vs PK₨0.07 in 3Q 2023)Third quarter 2024 results: EPS: PK₨1.68 (up from PK₨0.07 in 3Q 2023). Revenue: PK₨2.78b (up 17% from 3Q 2023). Net income: PK₨146.3m (up PK₨141.0m from 3Q 2023). Profit margin: 5.3% (up from 0.2% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.お知らせ • Oct 18Pakistan Oxygen Limited Appoints Jamshed Azhar as the Chief Financial OfficerPakistan Oxygen Limited has officially appointed Mr. Jamshed Azhar as the Chief Financial Officer (CFO) of the company, effective from October 14, 2024. The letter was signed by Maqsoor Iqbal, the Company Secretary of Pakistan Oxygen Limited, who expressed the board's confidence in Mr. Azhar's capabilities to steer the financial operations of the company. The communication also instructed that the TRE Certificate Holders of the exchange be informed of this significant change in the company's leadership. This decision comes as part of Pakistan Oxygen's ongoing enhancements to its executive team, aiming to strengthen its market position and operational efficiency. Mr. Azhar brings extensive experience in financial management, which is anticipated to be vital as the company continues to expand and adapt to the dynamic market demands.New Risk • Aug 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 3.8% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Profit margins are more than 30% lower than last year (3.1% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (PK₨9.69b market cap, or US$34.8m).Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 25%After last week's 25% share price gain to PK₨113, the stock trades at a trailing P/E ratio of 34.1x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 21% over the past three years.お知らせ • Jun 27Pakistan Oxygen Limited Announces Appointment of Nadir Salar Qureshi as Independent DirectorPakistan Oxygen Limited has officially appointed Mr. Nadir Salar Qureshi as an Independent Director, effective from June 20, 2024. This decision, taken through a resolution passed by circulation, sees Mr. Qureshi stepping into the role formerly held by Mr. Jahangir Piracha.Reported Earnings • May 02First quarter 2024 earnings released: EPS: PK₨2.05 (vs PK₨0.46 in 1Q 2023)First quarter 2024 results: EPS: PK₨2.05 (up from PK₨0.46 in 1Q 2023). Revenue: PK₨2.73b (up 50% from 1Q 2023). Net income: PK₨178.4m (up 436% from 1Q 2023). Profit margin: 6.5% (up from 1.8% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.New Risk • Apr 11New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 3.7% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.7% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (PK₨6.93b market cap, or US$24.9m).Reported Earnings • Apr 04Full year 2023 earnings released: EPS: PK₨1.66 (vs PK₨5.74 in FY 2022)Full year 2023 results: EPS: PK₨1.66 (down from PK₨5.74 in FY 2022). Revenue: PK₨8.59b (up 18% from FY 2022). Net income: PK₨144.7m (down 66% from FY 2022). Profit margin: 1.7% (down from 5.8% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 18%After last week's 18% share price gain to PK₨105, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 6x in the Chemicals industry in Pakistan. Total returns to shareholders of 33% over the past three years.New Risk • Nov 10New major risk - Revenue and earnings growthEarnings have declined by 0.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Earnings have declined by 0.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Profit margins are more than 30% lower than last year (2.0% net profit margin). Market cap is less than US$100m (PK₨6.54b market cap, or US$22.8m).Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: PK₨0.53 (vs PK₨1.33 in 3Q 2022)Third quarter 2023 results: EPS: PK₨0.53 (down from PK₨1.33 in 3Q 2022). Revenue: PK₨6.07b (up 236% from 3Q 2022). Net income: PK₨39.0m (down 60% from 3Q 2022). Profit margin: 0.6% (down from 5.4% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improves as stock rises 19%After last week's 19% share price gain to PK₨85.79, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total loss to shareholders of 2.1% over the past three years.New Risk • Sep 02New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.4% Last year net profit margin: 6.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). High level of non-cash earnings (34% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (3.4% net profit margin). Market cap is less than US$100m (PK₨5.30b market cap, or US$17.3m).Reported Earnings • Sep 02Second quarter 2023 earnings released: EPS: PK₨0.01 (vs PK₨1.15 in 2Q 2022)Second quarter 2023 results: EPS: PK₨0.01 (down from PK₨1.15 in 2Q 2022). Revenue: PK₨1.88b (down 2.9% from 2Q 2022). Net income: PK₨413.0k (down 100% from 2Q 2022). Profit margin: 0% (down from 4.4% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Apr 13Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to PK₨125, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 8x in the Chemicals industry in Pakistan. Total returns to shareholders of 50% over the past three years.Reported Earnings • Apr 06Full year 2022 earnings released: EPS: PK₨7.17 (vs PK₨7.70 in FY 2021)Full year 2022 results: EPS: PK₨7.17 (down from PK₨7.70 in FY 2021). Revenue: PK₨7.30b (up 4.2% from FY 2021). Net income: PK₨420.1m (down 6.9% from FY 2021). Profit margin: 5.8% (down from 6.4% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 22% per year.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Mohammad Dagha was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 30Third quarter 2022 earnings released: EPS: PK₨1.66 (vs PK₨2.18 in 3Q 2021)Third quarter 2022 results: EPS: PK₨1.66 (down from PK₨2.18 in 3Q 2021). Revenue: PK₨1.81b (flat on 3Q 2021). Net income: PK₨97.4m (down 24% from 3Q 2021). Profit margin: 5.4% (down from 7.1% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 17% per year.お知らせ • Oct 27Pakistan Oxygen Limited Appoints Mohammad Iqbal Puri as DirectorPakistan Oxygen Limited announced that Mr. Mohammad Iqbal Puri has been appointed as Director of the company with effect from October 25, 2022 in place of Mr. Shahid Abdul Sattar.Reported Earnings • Sep 01Second quarter 2022 earnings released: EPS: PK₨1.44 (vs PK₨1.90 in 2Q 2021)Second quarter 2022 results: EPS: PK₨1.44 (down from PK₨1.90 in 2Q 2021). Revenue: PK₨1.94b (down 4.4% from 2Q 2021). Net income: PK₨84.5m (down 24% from 2Q 2021). Profit margin: 4.4% (down from 5.5% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • May 01First quarter 2022 earnings released: EPS: PK₨2.56 (vs PK₨1.85 in 1Q 2021)First quarter 2022 results: EPS: PK₨2.56 (up from PK₨1.85 in 1Q 2021). Revenue: PK₨1.83b (up 20% from 1Q 2021). Net income: PK₨120.2m (up 11% from 1Q 2021). Profit margin: 6.6% (down from 7.1% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 16% per year.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Mohammad Dagha was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 06Full year 2021 earnings released: EPS: PK₨9.62 (vs PK₨7.39 in FY 2020)Full year 2021 results: EPS: PK₨9.62 (up from PK₨7.39 in FY 2020). Revenue: PK₨7.01b (up 26% from FY 2020). Net income: PK₨451.1m (up 30% from FY 2020). Profit margin: 6.4% (up from 6.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 13% per year.Reported Earnings • Oct 29Third quarter 2021 earnings released: EPS PK₨2.73 (vs PK₨2.66 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: PK₨1.81b (up 3.2% from 3Q 2020). Net income: PK₨128.1m (up 2.9% from 3Q 2020). Profit margin: 7.1% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year.Reported Earnings • Aug 31Second quarter 2021 earnings released: EPS PK₨2.38 (vs PK₨0.51 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: PK₨2.03b (up 86% from 2Q 2020). Net income: PK₨111.4m (up 366% from 2Q 2020). Profit margin: 5.5% (up from 2.2% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 11% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • May 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to PK₨150, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 8x in the Chemicals industry in Pakistan. Total returns to shareholders of 23% over the past three years.Reported Earnings • May 01First quarter 2021 earnings released: EPS PK₨2.78 (vs PK₨0.35 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: PK₨1.52b (up 27% from 1Q 2020). Net income: PK₨108.7m (up PK₨92.0m from 1Q 2020). Profit margin: 7.1% (up from 1.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to PK₨135, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 10x in the Chemicals industry in Pakistan. Total loss to shareholders of 9.4% over the past three years.Is New 90 Day High Low • Mar 11New 90-day low: PK₨146The company is down 8.0% from its price of PK₨159 on 11 December 2020. The Pakistani market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.Reported Earnings • Mar 02Full year 2020 earnings released: EPS PK₨8.87 (vs PK₨7.70 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: PK₨5.55b (up 19% from FY 2019). Net income: PK₨346.3m (up 15% from FY 2019). Profit margin: 6.2% (down from 6.4% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Jan 12New 90-day high: PK₨173The company is up 16% from its price of PK₨149 on 14 October 2020. The Pakistani market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.Reported Earnings • Oct 22Third quarter earnings releasedOver the last 12 months the company has reported total profits of PK₨195.7m, down 47% from the prior year. Total revenue was PK₨5.17b over the last 12 months, up 8.4% from the prior year.Is New 90 Day High Low • Sep 24New 90-day low: PK₨153The company is down 10.0% from its price of PK₨170 on 26 June 2020. The Pakistani market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.株主還元PAKOXYPK ChemicalsPK 市場7D0.5%4.3%3.3%1Y87.8%41.1%35.2%株主還元を見る業界別リターン: PAKOXY過去 1 年間で41.1 % の収益を上げたPK Chemicals業界を上回りました。リターン対市場: PAKOXY過去 1 年間で35.2 % の収益を上げたPK市場を上回りました。価格変動Is PAKOXY's price volatile compared to industry and market?PAKOXY volatilityPAKOXY Average Weekly Movement5.0%Chemicals Industry Average Movement6.4%Market Average Movement6.7%10% most volatile stocks in PK Market9.9%10% least volatile stocks in PK Market4.1%安定した株価: PAKOXY 、 PK市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: PAKOXYの 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1935150Matin Amjadwww.pakoxygen.comパキスタン・オキシジェン・リミテッド（Pakistan Oxygen Limited）は、パキスタンで産業用・医療用ガス、医療エンジニアリング、パイプライン設計サービス、医療機器、溶接製品、関連ソリューションの製造・販売を行っている。産業・医療・その他ガス、溶接・その他の2つのセグメントで事業を展開。液体および圧縮医療用酸素、亜酸化窒素、エントノックス、特殊医療用ガス、医療用空気、真空、AGSSプラント、医療用ガス警報システム、吸引インジェクターユニット、真空コントローラー、酸素療法製品、高精度流量計、エントノックス供給システム、半自動および全自動患者用ベッドヘッドユニット、ICUビームシステム、手術室ペンダント、完全装備のモジュラー式OT Oxymed、パイプラインおよびトレーラー水素ガス、産業用パイプラインサービス、ドライアイスを提供。また、医療ガス用アラームシステム、精密流量計、吸引インジェクターユニット、真空コントローラー、酸素療法製品、マニホールド、患者用ベッドヘッドユニット、ICUビームシステム、完全装備型モジュール式OTの販売、医療ガスパイプラインシステムのコンサルティング、設計、設置、サービス、医療ガスパイプラインシステムに関する安全性、品質、リスク分析、トレーニング、その他のサービスも提供している。さらに、圧縮酸素、窒素、アルゴン、空気、パイプライン、トレーラー水素、炭酸ガス、航空用酸素、溶解アセチレンガス、純度、研究グレード、滅菌ガス、ガス状化学物質、校正、溶接用混合ガス、オキシガイザー、クイックアップH、テレテル、溶接消耗品と機械、ガスレギュレーター、切断トーチ、溶接トーチ、切断機からなる溶接アクセサリーを提供。航空機、自動車、化学薬品、上下水道処理、溶接・金属加工、エネルギー、食品・飲料、ガラス、ヘルスケア、衛生、研究所、金属・材料加工、石油・ガス、製薬、精製などの業界にサービスを提供している。同社は以前はリンデ・パキスタン・リミテッドとして知られ、2018年2月にパキスタン・オキシジェン・リミテッドに社名を変更した。Pakistan Oxygen Limitedは1935年に設立され、パキスタンのカラチに本社を置いている。もっと見るPakistan Oxygen Limited 基礎のまとめPakistan Oxygen の収益と売上を時価総額と比較するとどうか。PAKOXY 基礎統計学時価総額PK₨24.52b収益（TTM）PK₨1.97b売上高(TTM)PK₨13.71b12.5xPER（株価収益率1.8xP/SレシオPAKOXY は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計PAKOXY 損益計算書（TTM）収益PK₨13.71b売上原価PK₨7.97b売上総利益PK₨5.75bその他の費用PK₨3.78b収益PK₨1.97b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）22.58グロス・マージン41.91%純利益率14.35%有利子負債／自己資本比率27.7%PAKOXY の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/19 14:58終値2026/06/19 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Pakistan Oxygen Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 16Pakistan Oxygen Limited Announces Resignation of Mazhar Iqbal as Company Secretary, Effective June 14, 2026Pakistan Oxygen Limited informed that Mr. Mazhar Iqbal has resigned from the position of Company Secretary of Pakistan Oxygen Limited, with effect from June 14, 2026.
お知らせ • Apr 14Pakistan Oxygen Limited to Report Q1, 2026 Results on Apr 27, 2026Pakistan Oxygen Limited announced that they will report Q1, 2026 results on Apr 27, 2026
Reported Earnings • Apr 12Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024)Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 04Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024)Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 03Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026. Location: west wharf, dockyard road, karachi Pakistan
お知らせ • Feb 14Pakistan Oxygen Limited to Report Fiscal Year 2025 Results on Feb 27, 2026Pakistan Oxygen Limited announced that they will report fiscal year 2025 results on Feb 27, 2026
お知らせ • Jun 16Pakistan Oxygen Limited Announces Resignation of Mazhar Iqbal as Company Secretary, Effective June 14, 2026Pakistan Oxygen Limited informed that Mr. Mazhar Iqbal has resigned from the position of Company Secretary of Pakistan Oxygen Limited, with effect from June 14, 2026.
お知らせ • Apr 14Pakistan Oxygen Limited to Report Q1, 2026 Results on Apr 27, 2026Pakistan Oxygen Limited announced that they will report Q1, 2026 results on Apr 27, 2026
Reported Earnings • Apr 12Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024)Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 04Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024)Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 03Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026. Location: west wharf, dockyard road, karachi Pakistan
お知らせ • Feb 14Pakistan Oxygen Limited to Report Fiscal Year 2025 Results on Feb 27, 2026Pakistan Oxygen Limited announced that they will report fiscal year 2025 results on Feb 27, 2026
お知らせ • Jan 30Pakistan Oxygen Limited Announces Directorate Changes, Effective January 30, 2026Pakistan Oxygen Limited elected directors at the extra ordinary genera meeting for a term of 3 years commencing from Janaury 30, 2026. Mr. Muhammad Ashraf Bawany, Mr. Arshad Mohsin Tayebaly Ms. Sadia Khan, Mrs. Saadia Naveed, Mr. Sohail Razi Khan.
Valuation Update With 7 Day Price Move • Nov 13Investor sentiment improves as stock rises 16%After last week's 16% share price gain to PK₨333, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 226% over the past three years.
Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to PK₨279, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 179% over the past three years.
お知らせ • Oct 15Pakistan Oxygen Limited to Report Q3, 2025 Results on Oct 24, 2025Pakistan Oxygen Limited announced that they will report Q3, 2025 results on Oct 24, 2025
Reported Earnings • Aug 29Second quarter 2025 earnings released: EPS: PK₨5.85 (vs PK₨1.52 in 2Q 2024)Second quarter 2025 results: EPS: PK₨5.85 (up from PK₨1.52 in 2Q 2024). Revenue: PK₨3.12b (up 13% from 2Q 2024). Net income: PK₨510.1m (up 285% from 2Q 2024). Profit margin: 16% (up from 4.8% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 37% per year whereas the company’s share price has increased by 34% per year.
New Risk • Aug 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.6x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (PK₨21.1b market cap, or US$74.6m).
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improves as stock rises 22%After last week's 22% share price gain to PK₨183, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 95% over the past three years.
Reported Earnings • Apr 28First quarter 2025 earnings released: EPS: PK₨4.49 (vs PK₨2.05 in 1Q 2024)First quarter 2025 results: EPS: PK₨4.49 (up from PK₨2.05 in 1Q 2024). Revenue: PK₨2.95b (up 8.1% from 1Q 2024). Net income: PK₨391.5m (up 119% from 1Q 2024). Profit margin: 13% (up from 6.5% in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year.
Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 19%After last week's 19% share price gain to PK₨161, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 9x in the Chemicals industry in Pakistan. Total returns to shareholders of 50% over the past three years.
お知らせ • Mar 03Pakistan Oxygen Limited, Annual General Meeting, Apr 24, 2025Pakistan Oxygen Limited, Annual General Meeting, Apr 24, 2025. Location: at the company`s registered office, west wharf, dockyard road, karachi Pakistan
お知らせ • Mar 01Pakistan Oxygen Limited Appoints Asad Said Jafar as Independent DirectorPakistan Oxygen Limited has announced the appointment of Mr. Asad Said Jafar as an Independent Director, succeeding Mr. Atif Aslam Bajwa. The decision was made during the company's Board of Directors meeting held on February 27, 2025. The appointment is effective immediately, from February 27, 2025. The Board of Directors has made this strategic appointment to ensure continued governance and oversight within the company. The company has not disclosed further details regarding the future direction or priorities under the new directorship, and it remains to be seen how Mr. Jafar's leadership will influence the company's trajectory.
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: PK₨1.68 (vs PK₨0.07 in 3Q 2023)Third quarter 2024 results: EPS: PK₨1.68 (up from PK₨0.07 in 3Q 2023). Revenue: PK₨2.78b (up 17% from 3Q 2023). Net income: PK₨146.3m (up PK₨141.0m from 3Q 2023). Profit margin: 5.3% (up from 0.2% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
お知らせ • Oct 18Pakistan Oxygen Limited Appoints Jamshed Azhar as the Chief Financial OfficerPakistan Oxygen Limited has officially appointed Mr. Jamshed Azhar as the Chief Financial Officer (CFO) of the company, effective from October 14, 2024. The letter was signed by Maqsoor Iqbal, the Company Secretary of Pakistan Oxygen Limited, who expressed the board's confidence in Mr. Azhar's capabilities to steer the financial operations of the company. The communication also instructed that the TRE Certificate Holders of the exchange be informed of this significant change in the company's leadership. This decision comes as part of Pakistan Oxygen's ongoing enhancements to its executive team, aiming to strengthen its market position and operational efficiency. Mr. Azhar brings extensive experience in financial management, which is anticipated to be vital as the company continues to expand and adapt to the dynamic market demands.
New Risk • Aug 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 3.8% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Profit margins are more than 30% lower than last year (3.1% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (PK₨9.69b market cap, or US$34.8m).
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 25%After last week's 25% share price gain to PK₨113, the stock trades at a trailing P/E ratio of 34.1x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 21% over the past three years.
お知らせ • Jun 27Pakistan Oxygen Limited Announces Appointment of Nadir Salar Qureshi as Independent DirectorPakistan Oxygen Limited has officially appointed Mr. Nadir Salar Qureshi as an Independent Director, effective from June 20, 2024. This decision, taken through a resolution passed by circulation, sees Mr. Qureshi stepping into the role formerly held by Mr. Jahangir Piracha.
Reported Earnings • May 02First quarter 2024 earnings released: EPS: PK₨2.05 (vs PK₨0.46 in 1Q 2023)First quarter 2024 results: EPS: PK₨2.05 (up from PK₨0.46 in 1Q 2023). Revenue: PK₨2.73b (up 50% from 1Q 2023). Net income: PK₨178.4m (up 436% from 1Q 2023). Profit margin: 6.5% (up from 1.8% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
New Risk • Apr 11New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 3.7% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.7% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (PK₨6.93b market cap, or US$24.9m).
Reported Earnings • Apr 04Full year 2023 earnings released: EPS: PK₨1.66 (vs PK₨5.74 in FY 2022)Full year 2023 results: EPS: PK₨1.66 (down from PK₨5.74 in FY 2022). Revenue: PK₨8.59b (up 18% from FY 2022). Net income: PK₨144.7m (down 66% from FY 2022). Profit margin: 1.7% (down from 5.8% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 18%After last week's 18% share price gain to PK₨105, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 6x in the Chemicals industry in Pakistan. Total returns to shareholders of 33% over the past three years.
New Risk • Nov 10New major risk - Revenue and earnings growthEarnings have declined by 0.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Earnings have declined by 0.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Profit margins are more than 30% lower than last year (2.0% net profit margin). Market cap is less than US$100m (PK₨6.54b market cap, or US$22.8m).
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: PK₨0.53 (vs PK₨1.33 in 3Q 2022)Third quarter 2023 results: EPS: PK₨0.53 (down from PK₨1.33 in 3Q 2022). Revenue: PK₨6.07b (up 236% from 3Q 2022). Net income: PK₨39.0m (down 60% from 3Q 2022). Profit margin: 0.6% (down from 5.4% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improves as stock rises 19%After last week's 19% share price gain to PK₨85.79, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total loss to shareholders of 2.1% over the past three years.
New Risk • Sep 02New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.4% Last year net profit margin: 6.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). High level of non-cash earnings (34% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (3.4% net profit margin). Market cap is less than US$100m (PK₨5.30b market cap, or US$17.3m).
Reported Earnings • Sep 02Second quarter 2023 earnings released: EPS: PK₨0.01 (vs PK₨1.15 in 2Q 2022)Second quarter 2023 results: EPS: PK₨0.01 (down from PK₨1.15 in 2Q 2022). Revenue: PK₨1.88b (down 2.9% from 2Q 2022). Net income: PK₨413.0k (down 100% from 2Q 2022). Profit margin: 0% (down from 4.4% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to PK₨125, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 8x in the Chemicals industry in Pakistan. Total returns to shareholders of 50% over the past three years.
Reported Earnings • Apr 06Full year 2022 earnings released: EPS: PK₨7.17 (vs PK₨7.70 in FY 2021)Full year 2022 results: EPS: PK₨7.17 (down from PK₨7.70 in FY 2021). Revenue: PK₨7.30b (up 4.2% from FY 2021). Net income: PK₨420.1m (down 6.9% from FY 2021). Profit margin: 5.8% (down from 6.4% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 22% per year.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Mohammad Dagha was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 30Third quarter 2022 earnings released: EPS: PK₨1.66 (vs PK₨2.18 in 3Q 2021)Third quarter 2022 results: EPS: PK₨1.66 (down from PK₨2.18 in 3Q 2021). Revenue: PK₨1.81b (flat on 3Q 2021). Net income: PK₨97.4m (down 24% from 3Q 2021). Profit margin: 5.4% (down from 7.1% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 17% per year.
お知らせ • Oct 27Pakistan Oxygen Limited Appoints Mohammad Iqbal Puri as DirectorPakistan Oxygen Limited announced that Mr. Mohammad Iqbal Puri has been appointed as Director of the company with effect from October 25, 2022 in place of Mr. Shahid Abdul Sattar.
Reported Earnings • Sep 01Second quarter 2022 earnings released: EPS: PK₨1.44 (vs PK₨1.90 in 2Q 2021)Second quarter 2022 results: EPS: PK₨1.44 (down from PK₨1.90 in 2Q 2021). Revenue: PK₨1.94b (down 4.4% from 2Q 2021). Net income: PK₨84.5m (down 24% from 2Q 2021). Profit margin: 4.4% (down from 5.5% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • May 01First quarter 2022 earnings released: EPS: PK₨2.56 (vs PK₨1.85 in 1Q 2021)First quarter 2022 results: EPS: PK₨2.56 (up from PK₨1.85 in 1Q 2021). Revenue: PK₨1.83b (up 20% from 1Q 2021). Net income: PK₨120.2m (up 11% from 1Q 2021). Profit margin: 6.6% (down from 7.1% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 16% per year.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Mohammad Dagha was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 06Full year 2021 earnings released: EPS: PK₨9.62 (vs PK₨7.39 in FY 2020)Full year 2021 results: EPS: PK₨9.62 (up from PK₨7.39 in FY 2020). Revenue: PK₨7.01b (up 26% from FY 2020). Net income: PK₨451.1m (up 30% from FY 2020). Profit margin: 6.4% (up from 6.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 13% per year.
Reported Earnings • Oct 29Third quarter 2021 earnings released: EPS PK₨2.73 (vs PK₨2.66 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: PK₨1.81b (up 3.2% from 3Q 2020). Net income: PK₨128.1m (up 2.9% from 3Q 2020). Profit margin: 7.1% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year.
Reported Earnings • Aug 31Second quarter 2021 earnings released: EPS PK₨2.38 (vs PK₨0.51 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: PK₨2.03b (up 86% from 2Q 2020). Net income: PK₨111.4m (up 366% from 2Q 2020). Profit margin: 5.5% (up from 2.2% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 11% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • May 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to PK₨150, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 8x in the Chemicals industry in Pakistan. Total returns to shareholders of 23% over the past three years.
Reported Earnings • May 01First quarter 2021 earnings released: EPS PK₨2.78 (vs PK₨0.35 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: PK₨1.52b (up 27% from 1Q 2020). Net income: PK₨108.7m (up PK₨92.0m from 1Q 2020). Profit margin: 7.1% (up from 1.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to PK₨135, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 10x in the Chemicals industry in Pakistan. Total loss to shareholders of 9.4% over the past three years.
Is New 90 Day High Low • Mar 11New 90-day low: PK₨146The company is down 8.0% from its price of PK₨159 on 11 December 2020. The Pakistani market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.
Reported Earnings • Mar 02Full year 2020 earnings released: EPS PK₨8.87 (vs PK₨7.70 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: PK₨5.55b (up 19% from FY 2019). Net income: PK₨346.3m (up 15% from FY 2019). Profit margin: 6.2% (down from 6.4% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Jan 12New 90-day high: PK₨173The company is up 16% from its price of PK₨149 on 14 October 2020. The Pakistani market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.
Reported Earnings • Oct 22Third quarter earnings releasedOver the last 12 months the company has reported total profits of PK₨195.7m, down 47% from the prior year. Total revenue was PK₨5.17b over the last 12 months, up 8.4% from the prior year.
Is New 90 Day High Low • Sep 24New 90-day low: PK₨153The company is down 10.0% from its price of PK₨170 on 26 June 2020. The Pakistani market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
